APACHE-acute physiology and chronic health evaluation: a physiologically based classification system.
W A Knaus, J E Zimmerman, D P Wagner...
https://pubmed.ncbi.nlm.nih.gov/7261642/Actively Recruiting
Led by Hospital Departamental de Villavicencio · Updated on 2026-05-27
1000
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are investigating factors associated with mortality in the intensive care unit ICU and evaluating the performance of the APACHE II score as a tool to predict mortality. The study focuses on critically ill adult patients admitted to the ICU in a hospital in Villavicencio, Colombia. It addresses the need to validate this score within a different population and healthcare setting, as current data in Colombia are limited. This observational study reviews records of all adult patients admitted to the ICU from January 2022 to June 2025, excluding those in intermediate care with lower therapeutic intervention scores. Data collected include demographic details, diagnosis, APACHE II and TISS-28 severity scores, mechanical ventilation duration, and outcomes such as mortality and ICU length of stay. Patients are grouped based on whether they died within 28 days or survived and were discharged alive within 24 days. Participants medical information is gathered retrospectively from clinical charts and entered into a standardized database. The APACHE II score is calculated within the first 24 hours of ICU admission. Researchers analyze mortality rates by disease and admission type, factors linked to mortality, and compare observed versus predicted mortality using statistical methods. The main outcome measured is mortality within 28 days, with careful monitoring of ICU stay and ventilation duration. The study is approved by an ethics committee and classified as low-risk research.
CONDITIONS
Factor Associated With Mortality in the ICU
N
Norton Perez Gutierrez, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Hospital Departamental de Villavicencio
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Participants are identified and included based on ICU admission records during the study period.
Duration - Up to 28 days after ICU admission
Participants are observed from ICU admission until discharge or death, with systematic data collection on clinical status and mortality risk factors.
Data is collected retrospectively from clinical records; no additional visits are required.
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
W A Knaus, J E Zimmerman, D P Wagner...
https://pubmed.ncbi.nlm.nih.gov/7261642/Xiaoqian Li, Qun Yi, Yuanming Luo...
https://pubmed.ncbi.nlm.nih.gov/39260355/Wijittra Liengswangwong, Ranchana Siriwannabhorn, Sittichok Leela-Amornsin...
https://pubmed.ncbi.nlm.nih.gov/39232644/Małgorzata Chlabicz, Wojciech Łaguna, Remigiusz Kazimierczyk...
https://pubmed.ncbi.nlm.nih.gov/39136422/Bilal Tekin, Jehat Kiliç, Gürhan Taşkin...
https://pubmed.ncbi.nlm.nih.gov/38377099/Suraj Sudarsanan, Praveen Sivadasan, Prem Chandra...
https://pubmed.ncbi.nlm.nih.gov/39550342/Hospital Departamental de Villavicencio
Lead Sponsor